Key facts
- It has raised $400K; the latest was Early Stage VC ($400K) in Jul 2025.
- Notable investors include Graduate Ventures, PLNT., UNIIQ.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Secuped
- ·The full record, as it builds
Funding rounds
No funding rounds for Secuped are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Secuped
Developer of a remote foot health monitoring device designed for early detection and prevention of diabetic foot ulcers. The company's platform offers home-based foot monitoring through easy-to-use hardware and secure digital reporting tools, enabling patients with diabetes and at-risk feet to detect issues between clinical visits and healthcare professionals to observe foot health trends remotely, intervene early with minimal effort, and reduce the need for wound care, improving outcomes and lowering treatment costs.
- Sector
- Healthcare
- HQ
- Leiden, Netherlands
- Founded
- 2023
- Website
- secuped.com/
- Ownership
- Privately Held (backing)
Secuped doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Secuped shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Secuped in its N-PORT filings yet. We sweep new filings monthly.